TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer

JIANFA WU & ZHOU LIU et al. · 2023-12-28

11Citations
The impact of different iron metabolism processes (DIMP) on ovarian cancer remains unclear. In this study, we employed various gene chips and databases to investigate the role of DIMP in the initiation and development of ovarian cancer. cBioPortal was used to determine mutations in DIMP-associated genes in ovarian cancer. Kaplan-Meier plotter was used to examine the influence of DIMP on the prognosis of ovarian cancer. By analyzing 1669 serous ovarian cancer cases, we identified a range of mutations in iron metabolism genes, notably in those coding for the transferrin receptor (19%), melanotransferrin (19%), and ceruloplasmin (10%) in the iron import process, and glucose-6-phosphate isomerase (9%), hepcidin antimicrobial peptide (9%), metal regulatory transcription factor 1 (8%), and bone morphogenetic protein 6 (8%) in the iron regulation process. Compared to the unaltered group, the group with gene alterations exhibited a higher tumor mutation burden count (43
TL;DR

DIMP plays multifaceted roles in the initiation, chemo-resistance, and prognosis of ovarian cancer and Therapeutically targeting DIMP may pave the way for more tailored treatment approaches for ovarian cancer.

AI-generated by Semantic Scholar

Authors
JIANFA WU, QIANYI LIAO, LI ZHANG, SUQIN WU, ZHOU LIU